ストックスクリーナーアプリを入手
23.67
1.87%
-0.45
アフターアワーズ：
23.64
-0.03
-0.13%
前日終値:
$24.12
開ける：
$24.19
24時間の取引高:
97,044
Relative Volume:
0.47
時価総額：
$462.73M
収益：
-
当期純損益:
$-83.49M
株価収益率:
-5.3107
EPS:
-4.457
ネットキャッシュフロー:
$-60.29M
1週間 パフォーマンス:
-12.33%
1か月 パフォーマンス:
-37.23%
6か月 パフォーマンス:
-23.79%
1年 パフォーマンス:
+60.91%
1日の値動き範囲:
$23.55
$24.66
1週間の範囲:
$23.06
$27.58
52週間の値動き範囲:
$14.60
$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Compare TECX vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
23.67 | 462.73M | 0 | -83.49M | -60.29M | -4.457 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-05-26 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2026-04-14 | 開始されました | Stifel | Buy |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-09-03 | 開始されました | Oppenheimer | Outperform |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-04-21 | 開始されました | Mizuho | Outperform |
| 2024-11-20 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-06-24 | 開始されました | TD Cowen | Buy |
| 2023-12-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-05 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-17 | 開始されました | H.C. Wainwright | Buy |
| 2018-07-16 | 開始されました | Wedbush | Outperform |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Tectonic Therapeutic Inc (TECX) 最新ニュース
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Capturing a Potential 181.61% Upside in the Biotech Sector - DirectorsTalk Interviews
TECX Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesEarnings Sentiment Score - dars.gov.et
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare - Yahoo Finance
Tectonic Therapeutic CFO Lochner Daniel Receives 24,250 Derivative Securities Award - Kalkine Media
Tectonic Therapeutic (TECX) ties CFO option grant to 42-month vesting schedule - Stock Titan
Tectonic Therapeutic (TECX) grants CEO 69,250 stock options with extended vesting - Stock Titan
Tectonic Therapeutic (TECX) awards CBO 17,750 stock options - Stock Titan
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewswire
Tectonic Therapeutic advances TX45 trial with s... - Pluang
Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case - Seeking Alpha
Tectonic Therapeutic Loses US$152m Market Value But Insiders See Windfall Of US$72k - simplywall.st
Tectonic (NASDAQ: TECX) ex-director lines up another stock sale - Stock Titan
Tectonic Therapeutic (NASDAQ: TECX) ex-director to sell 10,200 shares - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.6% HigherShould You Buy? - MarketBeat
TECX Q2 2026 Earnings: Narrower-than-Expected Loss Lifts Shares 2.74%Earnings Surprise Report - vinanet.vn
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India
TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - MarketBeat
Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo
Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
TECX Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Wells Fargo & Company Issues Pessimistic Forecast for Tectonic Therapeutic (NASDAQ:TECX) Stock Price - MarketBeat
Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring A 159.58% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Tectonic Therapeutic, Inc. Stock 12‑Month Price Target Cut to $77.56, Implies 157% Upside - TradingView
Tectonic Therapeutic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tectonic Therapeutic, Inc. 2Q 2026: Net loss $22.3M, EPS $(1.18) — 10-Q Summary - TradingView
TECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingView
Press Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
TECX,RNAC Options - Finviz
Tectonic Therapeutic Inc expected to post a loss of $1.35 a shareEarnings Preview - TradingView
Tectonic Therapeutic (TECX) Holds Ground at $27.95 as Traders Eye $26.55 SupportAAII Bullish - dars.gov.et
TECX Q1 2026 Earnings: Wider-Than-Expected Loss of $1.34 Per Share as Pre-Revenue Pipeline AdvancesEPS Surprise History - careplusvn.com
TECX Q1 2026 Earnings: EPS Misses Expectations, Stock Slips on Wider LossEstimate Dispersion - careplusvn.com
Tectonic Therapeutic Inc (TECX) Valuation: PE, PB & Fair Value Analysis - TradingKey
TECX|Tectonic Therapeutic Inc|Price:35.620|Chg%:-1.080 - TradingKey
Tectonic Therapeutic Inc (TECX) Cash Flow - TradingKey
TECX|Tectonic Therapeutic Inc|Price:30.590|Chg%:+0.220 - TradingKey
First Light Asset Management LLC Takes $20.02 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
Tectonic Therapeutic Inc (TECX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tectonic Therapeutic Inc (TECX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tectonic Therapeutic Inc (TECX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tectonic Therapeutic Inc (TECX) 財務データ
収益
当期純利益
現金流量
EPS
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):